Skip to content

Adapting and Expanding the Asthma-Educator App

Adapting and Expanding the Algorithmic Software Tool to Help Manage Asthma (ASTHMAXcel) for Youth With Asthma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03930381
Enrollment
80
Registered
2019-04-29
Start date
2018-05-01
Completion date
2023-07-01
Last updated
2023-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Asthma

Brief summary

This project seeks to test and refine an adapted/expanded version of a previously created ASTHMAXcel app.

Detailed description

The study will test the adapted app on participants ages 15-21 (recruited from outpatient primary and specialty care sites at Montefiore) with asthma, for a period of 4 and a half months, and will conduct formative and summative evaluation of the application's functionality and usability. The investigators will also be collecting process and clinical outcomes.

Interventions

OTHERASTHMAXcel App

ASTHMAXcel includes interactive games, educational videos, quizzes and personalized feedback to teach different aspects of asthma management.

Sponsors

Montefiore Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Study will eventually compare health outcomes between a group given the ASTHMAXcel intervention and a group given Usual Care

Eligibility

Sex/Gender
ALL
Age
15 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* English-speaking individuals between 15-21 * Persistent asthma (diagnosis made by a healthcare provider) * On a daily controller medication * Able to give informed consent * Smartphone (iOS or Android) access

Exclusion criteria

* Use of oral corticosteroids in the 2 weeks prior to the baseline visit * Pregnancy * Severe psychiatric or cognitive problems that would prohibit an individual from understanding and completing the protocol * Patients that previously received the ASTHMA-Educator application

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline Asthma Control to 3 Month Asthma ControlPost-Refinement Baseline, 3 MonthsAsthma symptom burden as measured by the Asthma Control Test Score Scale: 5 (min = worse); 25 (max = better outcome)

Secondary

MeasureTime frameDescription
Asthma KnowledgePost-Refinement Baseline, 3 MonthWill use the Child Asthma Illness Representation Survey (AIRS) to asses patients knowledge on asthma as well as their attitudes towards their condition. Score Scale: 4 (min = worse outcome); 20 (max = better outcome)
Medication AdherencePost-Refinement Baseline, 3 MonthSelf-reported adherence by patient using Medication Adherence Report Scale Score Scale: 10 (min = worse outcome); 50 (max = better outcome)
Asthma Quality of LifePost-Refinement Baseline, 3 MonthQuality of life of participants, measured by mini-Asthma Quality of Life Questionnaire Score Scale: 15 (min = worse outcome); 105 (max = better outcome)
Emergency Department VisitsPost-Refinement Baseline, 3 MonthSelf-Reported Emergency Department (ED) visits
Asthma Symptom PerceptionWeek 2, Week 4 , Week 6 (Pre and Post Refinement)Ability of participants to perceive their asthma symptoms by using the ASTHMAXcel app and a peak flowmeter
Patient Interface SatisfactionPost-Refinement Baseline, 3 MonthPatient satisfaction with ASTHMAXcel app interface measured by Questionnaire for User Interface Survey (QUIS) Score Scale: 0 (min = worse outcome); 261 (max = better outcome) Answers scale from 0 (terrible/hard to understand)) to 9 (wonderful/easy to understand)
Patient UsageBaseline, 3 MonthTime spent on app and different screens of app, measured using Google Analytics
Health LiteracyPost-Refinement BaselineAbility for patients to comprehend Newest Vital Sign screening tool
Patient SatisfactionPost-Refinement Baseline, 3 MonthPatient satisfaction with study measured by the Client Satisfaction Questionnaire-8 Score Scale: 8 (min = worse outcome); 32 (max = better outcome)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026